Answers are grounded in this paper and cite their sources.
Foot-and-mouth disease virus-like particles (FMDV VLPs) vaccine represents a safer alternative to classic inactivated vaccine. However, stable production of FMDV VLPs in mammalian cells remains challenging due to the cellular toxicity associated with expression of viral 3C protease (3Cpro), which is responsible for processing the P12A polyprotein. This study established a stable inducible Chinese hamster ovary (CHO) cell platform for FMDV VLPs production by combining the P12A3C(L127P) gene with a piggyBac-based Tet-On expression system. CHO cells were transfected with P12A3C genes containing either wild-type (WT) or L127P-mutated 3Cpro under constitutive or doxycycline-inducible promoters. Neither constitutive expression of P12A3C(WT) or P12A3C(L127P), nor inducible expression of P12A3C(WT), resulted in successful establishment of cell pools. In contrast, the inducible expression of P12A3C(L127P) enabled generation of a stable recombinant cell pool with low basal expression and doxycycline-inducible expression of FMDV capsid proteins. The established cell pool maintained capsid proteins expression during 25 serial passages and produced assembled VLPs after induction. The purified particles elicited virus-specific and neutralizing antibody responses and provided 85.7% protection against challenge in guinea pigs. These findings demonstrate that coordinated optimization of viral protein design and expression control is important for establishing stable mammalian cell platforms for FMDV VLP production. Key points • A piggyBac-Tet-On system enabled stable CHO cell pool establishment. • The I-L127P cell pool maintained inducible capsid expression through P25. • FMDV VLPs induced neutralizing antibodies and 85.7% protection in guinea pigs.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: